Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Lydaxx 100mg/ml solution recalled over sterility concerns
The recall affects a single batch of Lydaxx 100mg/ml solution for cattle, pigs and sheep.
Product may be compromised owing to crimping of the aluminium cap.

The Veterinary Medicines Directorate (VMD) has issued a product defect recall alert for Lydaxx 100mg/ml solution for cattle, pigs and sheep following sterility concerns.

The recall affects a single batch of the product -
Batch No.0C3829 Expiry Date 03/12/2022 - manufactured by Vetoquinol UK Ltd.

The recall states: “We wish to make wholesalers and veterinary surgeons aware that Vetoquinol UK Ltd has initiated a Class I recall of Lydaxx 100 mg/ml solution for injection for cattle, pigs and sheep as a precautionary measure.

“Vetoquinol have identified that there is a potential for the sterility/stability of the product to be compromised due to a crimping problem of the aluminium cap. This recall is for the 100 ml bottles of the following batch only: Batch No.0C3829 Expiry Date 03/12/2022."

Veterinary surgeons and wholesale dealers are being contacted by Vetoquinol UK Ltd to examine their inventory immediately and quarantine products subject to this recall.

More information about the recall can be obtained from Vetoquinol’s Customer Services Department on +44 1280 814500 Option 1 or email: UK_office@vetoquinol.com

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.